Career Development Series

Startups at National Biotechnology Research Park


Would you like to learn about the entrepreneurial journey in Taiwanese startups? Are you curious about the support that the National Biotechnology Parks can offer to entrepreneurs? Then you definitely shouldn’t miss the online seminar in June hosted by BTBA! We are honored to invite two founders/directors from startups based in the National Biotechnology Research Parks to share their experiences. Our speakers will discuss how they brought their experience from working in major pharmaceutical companies abroad back to Taiwan to establish their own companies. They will also share their success stories of transferring academic technologies in Taiwan to their companies and entering the U.S. market. Don’t hesitate—click the link below to register for this event!

🗣️ 本實體活動全程以中文進行

▶️ 主題 / Topic: Startups at National Biotechnology Research Park

🕘 Time: 2024-05-19 (Sun)

  • 美東: 2024年06月07日 (星期五) 9:00 PM - 10:30 PM
  • 台灣: 2024年06月08日 (星期六) 9:00 AM - 10:30 AM

▶️ 報名連結/RSVP:

▶️ Contact: BTBA聯絡窗口;

▶️ Speakers:

  • 👩‍💼 Dr. Tess Lu 呂采修 Director (Research), Ochre Bio, Taiwan
  • 👨‍💼 Dr. Jung-Chi Liao 廖仲麒 | Chairman, CEO, and Founder at Syncell, Taiwan ▶ ️ Moderators:
  • Dr. Chih-Hsiang Yang 楊志祥 Postdoctoral Associate at UMass Chan Medical School


Dr. Tess Lu 呂采修

Director (Research), Ochre Bio, Taiwan

Trained as a scientist in epigenetics and metabolic diseases, Tess made her transition to the industry as a STAR Post-doctoral fellow at Novo Nordisk working on GLP-1’s regulation on appetite. She continued her career at Novo Nordisk as a scientist and senior scientist at the Stem Cell Department, setting up the first single-cell platform in the company. After her maternity break, she made the transition back to Taiwan and started the Taipei chapter as Research Director for Ochre Bio, a liver RNA-therapeutics company headquartered in Oxford UK.

Linkedin page:

Dr. Jung-Chi Liao 廖仲麒

Chairman, CEO, and Founder at Syncell, Taiwan

Dr. Jung-Chi Liao was a Research Fellow at Academia Sinica, Taiwan and an Assistant Professor at Columbia University, New York before he founded Syncell in 2020, a spinoff company with its innovative optoproteomics technology invented in his lab at Academia Sinica. Under his guidance, the Syncell team is advancing the Microscoop product development and business strategy to realize Syncell’s vision to become a dominant player in spatial omics. Dr. Liao takes a precision synergy approach to create a cooperative and efficient culture suitable for multidisciplinary communication. Having been immersed in the high-tech spinoff environment at MIT, Cal Berkeley, Stanford, and Columbia, he shapes Syncell to match the high caliber and advance toward a leading global life science technology company.

Linkedin page:


Dr. Chih-Hsiang Yang 楊志祥

Postdoctoral Associate at UMass Chan Medical School

Dr. Yang is a passionate scientist with expertise in rodent models, epigenetics, obesity/diabetes, and metabolism. He’s especially fascinated by the paternal intergenerational effect when encountering environmental factors. He worked at the Max Planck Institute of Immunobiology and Epigenetics and received his Ph.D. from the University of Freiburg, Germany. In his Ph.D. work, he focused on the role of Neuronatin (Nnat) in buffering metabolic variation as an outcome of overgrowth/obesity encountering unknown environmental factors. He observed a bi-stable body composition phenotype in the Nnat deficient mouse model and further explored the causal mechanism mediated by HDAC-related gene profile via genomic approaches. The key concept from the story is to reshape people’s views on obesity subtypes in mammals from mice to human beings. As a postdoctoral fellow, he joined Rando’s laboratory at UMass Chan Medical School, studying paternal epigenetic inheritance effect on offspring when parents are exposed to the high-fat diet or paternal aging.

Linkedin page:

2024-06-07, 9–10:30 PM ET

Register here